Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.

Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.

Item
http://www.wikidata.org/entity/Q33737470
Cystamine preparations exhibit anticoagulant activityBlockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP ratsPreeclampsia and Pregnancy-Related Hypertensive DisordersInvolvement of transglutaminase 2 and voltage-gated potassium channels in cystamine vasodilatation in rat mesenteric small arteries.Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia.Transglutaminase is a Critical Link Between Inflammation and Hypertension.Protein Phosphotyrosine Phosphatase 1B (PTP1B) in Calpain-dependent Feedback Regulation of Vascular Endothelial Growth Factor Receptor (VEGFR2) in Endothelial Cells: IMPLICATIONS IN VEGF-DEPENDENT ANGIOGENESIS AND DIABETIC WOUND HEALING.Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase.Transglutaminase 2 in human diseases.The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension.
P2860

Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.

Item
http://www.wikidata.org/entity/Q33737470
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Tissue transglutaminase contri ...... nting isopeptide modification.
@ast
Tissue transglutaminase contri ...... nting isopeptide modification.
@en
type
label
Tissue transglutaminase contri ...... nting isopeptide modification.
@ast
Tissue transglutaminase contri ...... nting isopeptide modification.
@en
prefLabel
Tissue transglutaminase contri ...... nting isopeptide modification.
@ast
Tissue transglutaminase contri ...... nting isopeptide modification.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Tissue transglutaminase contri ...... nting isopeptide modification.
@en
P2093
P2860
P304
P31
P356
10.1161/HYPERTENSIONAHA.113.02361
P407
P433
P478
P577
P5875
P698
P921
P932